BusinessIsodiol International Inc. Closes First Tranche of Strategic FinancingBy Nasdaq OMXDec 21, 2017, 6:03 PM UTC
BusinessNewLink Genetics to Present at the 36th Annual J.P. Morgan Healthcare ConferenceBy Nasdaq OMXDec 21, 2017, 2:00 PM UTC
BusinessAsklepion Pharmaceuticals Announces Special Protocol Assessment (SPA) Agreement with FDA for Phase 3 Program of Intravenous CitrullineBy Nasdaq OMXDec 19, 2017, 2:01 PM UTC
BusinessINSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy in Pediatric PatientsBy Nasdaq OMXDec 19, 2017, 1:01 PM UTC
BusinessAmarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits to Commence in March 2018By Nasdaq OMXDec 19, 2017, 11:00 AM UTC
BusinessAmarin to Present at 36th Annual J.P. Morgan Healthcare Conference in San FranciscoBy Nasdaq OMXDec 18, 2017, 9:30 PM UTC
BusinessPolydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial ResultsBy Nasdaq OMXDec 15, 2017, 2:20 PM UTC
BusinessAclaris Therapeutics Receives FDA Approval for ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses (SKs)By Nasdaq OMXDec 15, 2017, 12:00 PM UTC
